Arya A - Search Results

1

Catheter ablation as first-line treatment for ventricular tachycardia in patients with structural heart disease and preserved left ventricular ejection fraction: a systematic review and meta-analysis.

Askarinejad A, Arya A, Zangiabadian M, Ghahramanipour Z, Hesami H, Farmani D, Ghanbari Mardasi K, Kohansal E, Haghjoo M. Askarinejad A, et al. Among authors: arya a. Sci Rep. 2024 Aug 9;14(1):18536. doi: 10.1038/s41598-024-69467-4. Sci Rep. 2024. PMID: 39122752 Free PMC article.

2

Radiofrequency catheter ablation of idiopathic left ventricular tachycardia originating in both left posterior and anterior fascicles.

Haghjoo M, Arya A, Emkanjoo Z, SadrAmeli MA. Haghjoo M, et al. Among authors: arya a. J Interv Card Electrophysiol. 2004 Dec;11(3):217-20. doi: 10.1023/B:JICE.0000048573.31001.d0. J Interv Card Electrophysiol. 2004. PMID: 15548889

3

Risk stratification for arrhythmic death after myocardial infarction: current perspective and future direction.

Arya A, Haghjoo M, Sadr-Ameli MA. Arya A, et al. Int J Cardiol. 2006 Apr 4;108(2):155-64. doi: 10.1016/j.ijcard.2005.05.011. Epub 2005 Jun 16. Int J Cardiol. 2006. PMID: 15964087 Review.

4

Coronary sinus mapping to differentiate left versus right ventricular outflow tract tachycardias.

Arya A, Haghjoo M, Emkanjoo Z, Sadr-Ameli MA. Arya A, et al. Europace. 2005 Sep;7(5):428-32. doi: 10.1016/j.eupc.2005.03.011. Europace. 2005. PMID: 16087105

5

Is the activation potential of Mahaim pathway always a fast potential? Implication for radiofrequency catheter ablation.

Haghjoo M, Arya A, Emkanjoo Z, Sadr-Ameli MA. Haghjoo M, et al. Among authors: arya a. Europace. 2005 Sep;7(5):440-6. doi: 10.1016/j.eupc.2005.05.006. Europace. 2005. PMID: 16087107

6

Can amiodarone prevent sudden cardiac death in patients with hemodynamically tolerated sustained ventricular tachycardia and coronary artery disease?

Arya A, Haghjoo M, Sadr-Ameli MA. Arya A, et al. Cardiovasc Drugs Ther. 2005 May;19(3):219-26. doi: 10.1007/s10557-005-2502-8. Cardiovasc Drugs Ther. 2005. PMID: 16142600 Review.

7

Effect of cardiac resynchronization therapy on the incidence of ventricular arrhythmias in patients with an implantable cardioverter-defibrillator.

Arya A, Haghjoo M, Dehghani MR, Alasti M, Alizadeh H, Kazemi B, Sadr-Ameli MA. Arya A, et al. Heart Rhythm. 2005 Oct;2(10):1094-8. doi: 10.1016/j.hrthm.2005.07.007. Heart Rhythm. 2005. PMID: 16188588

8

Resolution of tachycardia-induced cardiomyopathy following ablation of verapamil-sensitive idiopathic left ventricular tachycardia.

Arya A, Haghjoo M, Davari P, Sadr-Ameli MA. Arya A, et al. Pediatr Cardiol. 2006 Jan-Feb;27(1):146-148. doi: 10.1007/s00246-005-1091-4. Pediatr Cardiol. 2006. PMID: 16391993

9

ICD therapy: what have we learned from the clinical trials?

Arya A, Haghjoo M, Sadr-Ameli MA. Arya A, et al. Heart Lung Circ. 2006 Feb;15(1):3-11. doi: 10.1016/j.hlc.2005.08.002. Epub 2005 Oct 21. Heart Lung Circ. 2006. PMID: 16473784 Review.

10

Value of microvolt T-wave alternans for predicting patients who would benefit from implantable cardioverter-defibrillator therapy.

Haghjoo M, Arya A, Sadr-Ameli MA. Haghjoo M, et al. Among authors: arya a. Cardiol Rev. 2006 Jul-Aug;14(4):173-9. doi: 10.1097/01.crd.0000184454.56306.d6. Cardiol Rev. 2006. PMID: 16788329 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

868 results

Search Page

Filters